Circumventing tolerance to a human MDM2-derived tumor antigen by TCR gene transfer.
about
TCR-Engineered T Cells Meet New Challenges to Treat Solid Tumors: Choice of Antigen, T Cell Fitness, and Sensitization of Tumor MilieuRetroviral transduction of peptide stimulated t cells can generate dual t cell receptor-expressing (bifunctional) t cells reactive with two defined antigensT cell avidity and tumor recognition: implications and therapeutic strategies.Adoptive T-cell therapy for LeukemiaGenetically modified T cells in cancer therapy: opportunities and challengesStructural and energetic evidence for highly peptide-specific tumor antigen targeting via allo-MHC restrictionTechnical Considerations for the Generation of Adoptively Transferred T Cells in Cancer ImmunotherapyT-cell receptor gene therapy--ready to go viral?How (specific) would like your T-cells today? Generating T-cell therapeutic function through TCR-gene transferAn efficient strategy to induce and maintain in vitro human T cells specific for autologous non-small cell lung carcinomaT-Cell Receptor-Engineered Cells for the Treatment of Hematologic Malignancies.Protocol for gene transduction and expansion of human T lymphocytes for clinical immunogene therapy of cancer.Redirecting human CD4+ T lymphocytes to the MHC class I-restricted melanoma antigen MAGE-A1 by TCR alphabeta gene transfer requires CD8alpha.T cell receptor-transgenic primary T cells as a tool for discovery of leukaemia-associated antigens.A study of T cell tolerance to the tumor-associated antigen MDM2: cytokines can restore antigen responsiveness, but not high avidity T cell functionSelection of human antibody fragments directed against tumor T-cell epitopes for adoptive T-cell therapy.Transduction of human T cells with a novel T-cell receptor confers anti-HCV reactivity.A critical role of T cell antigen receptor-transduced MHC class I-restricted helper T cells in tumor protection.Long-term in vivo provision of antigen-specific T cell immunity by programming hematopoietic stem cells.Generation of functional antigen-specific T cells in defined genetic backgrounds by retrovirus-mediated expression of TCR cDNAs in hematopoietic precursor cells.Exploiting T cells specific for human minor histocompatibility antigens for therapy of leukemia.Immunotherapy of human cancers using gene modified T lymphocytes.Clinical application of genetically modified T cells in cancer therapy.Current status of adoptive immunotherapy of malignancies.Redirecting cytotoxic T lymphocyte responses with T-cell receptor transgenes.T-cell therapy of leukemia.T cells targeting carcinoembryonic antigen can mediate regression of metastatic colorectal cancer but induce severe transient colitis.Genetically engineered T cells for the treatment of cancer.Transfer of a TCR gene derived from a patient with a marked antitumor response conveys highly active T-cell effector functions.A sense of tumour for the immune system.Adoptive cellular therapy: a therapeutic reality?CD8 T cell tolerance to a tumor-associated self-antigen is reversed by CD4 T cells engineered to express the same T cell receptorHigh-throughput identification of antigen-specific TCRs by TCR gene capture.Targeting tumours with genetically enhanced T lymphocytes.Prospects for immunotherapy of malignant disease.Redirecting T lymphocyte specificity using T cell receptor genes.Generating HPV specific T helper cells for the treatment of HPV induced malignancies using TCR gene transfer.Human adenovirus-specific γ/δ and CD8+ T cells generated by T-cell receptor transfection to treat adenovirus infection after allogeneic stem cell transplantation.Identification of NY-BR-1-specific CD4(+) T cell epitopes using HLA-transgenic mice.Increased intensity lymphodepletion and adoptive immunotherapy--how far can we go?
P2860
Q21131200-D922985F-64E9-4095-9B3A-A596AFD777F3Q24801977-1BD89DEC-2544-449A-B551-F9ADCD945397Q24815775-341DE40A-8522-408C-8746-FBFC4B73CAB4Q27006934-167150CB-855D-4845-96FB-47B6C811D0F7Q27026627-DE521709-F871-46A7-BF11-1B494B7DC5FAQ27676136-58EB6558-93A3-4D3C-BBFA-142D6767706BQ28073563-E3950137-DB64-472B-9F5F-8C4EE36BA554Q28081611-ED7154B4-6320-480E-81F2-4CDBB6AA9362Q28727481-1B28C92A-E614-438F-AAF0-F21CCCEC4DEFQ28749871-D0D50824-9EF7-4F5B-B8A2-78DD7413AA5AQ30251555-0DF3575A-918A-4E98-9D72-603105CCC5A3Q33183860-58F6F409-0B96-4C94-A067-EE71953538FEQ33208099-97172CCC-3929-4AAC-A7E5-CC4DF103B9D4Q33230010-BBB279DB-60B6-4C10-B00A-80F54DDAD94DQ33281005-A3DA0EB8-C773-40CC-9E04-776D81A5FB46Q33368725-5E398067-9DC7-4798-B746-7274FC4A7E4FQ33649735-260089C4-2B7A-4640-A28B-D15169E9A4FCQ33841127-90076828-5E46-4318-A1BE-8142374B1F49Q33928413-6F386C3F-9BBE-4317-841D-FDF17E8456C0Q34028508-54B60CD0-1842-4111-A068-47BA9B24E80BQ34163218-2ED297E8-F4B8-40CC-B713-AF397267AF23Q34188383-C7A51CDB-0128-4674-AF50-35F0C8C8E7F2Q34511646-16319577-AB88-49DD-BF00-8255E9C35279Q34560649-ACB8F02F-E397-426F-B1AA-0A46F21CACC5Q34602524-5840E3BE-D6CD-4FEE-9C6B-EC10FF730A35Q34608658-88E0D5E6-11D9-45DC-98A4-7810A6BFBD9FQ34621730-3D1E5993-9DB3-4CD7-B996-B8194D022D32Q34645898-5D1C6C9A-147D-4C23-9FD2-91DFEEA164D8Q34669675-84401C90-14F7-482A-ACD6-413E81EA85B4Q34842108-32C704E5-F4CF-4963-863E-E0552D41EAB3Q34875170-E75B6C7D-1A35-4914-BD97-16218FAD5296Q34981606-028C0873-8171-41B1-B255-F473D30486F9Q35016476-DFB75196-34E3-46B4-88BC-F8A7E5E8C5EAQ35037678-6621C7C4-E04B-4192-9877-21FB74555104Q35041705-25415D97-2CB9-423A-98FE-244085A04D11Q35126976-EE73F1B1-4655-4392-8A42-019817459BCEQ35221732-B7435E95-6DC5-4102-876D-69783809A9DBQ35308252-7737A5B5-4D80-4383-A93B-5A5D46209DB2Q35411077-66C8A2E2-C8F7-42A7-940D-C7676CC09AD6Q35594089-353B30A7-2DDF-49BB-A693-3F24A31BBAEE
P2860
Circumventing tolerance to a human MDM2-derived tumor antigen by TCR gene transfer.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Circumventing tolerance to a human MDM2-derived tumor antigen by TCR gene transfer.
@en
type
label
Circumventing tolerance to a human MDM2-derived tumor antigen by TCR gene transfer.
@en
prefLabel
Circumventing tolerance to a human MDM2-derived tumor antigen by TCR gene transfer.
@en
P2093
P2860
P356
P1433
P1476
Circumventing tolerance to a human MDM2-derived tumor antigen by TCR gene transfer.
@en
P2093
C J Melief
E Sadovnikova
H J Stauss
M Theobald
R A Willemsen
R L Bolhuis
P2860
P2888
P304
P356
10.1038/NI1001-962
P407
P577
2001-10-01T00:00:00Z
P6179
1030557527